Your browser doesn't support javascript.
loading
Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer.
Liu, Min; Tayob, Nabihah; Penter, Livius; Sellars, MacLean; Tarren, Anna; Chea, Vipheaviny; Carulli, Isabel; Huang, Teddy; Li, Shuqiang; Cheng, Su-Chun; Le, Phuong; Frackiewicz, Laura; Fasse, Julia; Qi, Courtney; Liu, Joyce F; Stover, Elizabeth H; Curtis, Jennifer; Livak, Kenneth J; Neuberg, Donna; Zhang, Guanglan; Matulonis, Ursula A; Wu, Catherine J; Keskin, Derin B; Konstantinopoulos, Panagiotis A.
Afiliação
  • Liu M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tayob N; Harvard Medical School, Boston, Massachusetts.
  • Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sellars M; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tarren A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Chea V; Department of Hematology, Oncology, and Tumor Immunology, Campus Virchow Klinikum, Berlin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Carulli I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Huang T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Li S; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cheng SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Le P; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Frackiewicz L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Fasse J; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Qi C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Liu JF; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Stover EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Curtis J; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Livak KJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Neuberg D; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Zhang G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Matulonis UA; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Keskin DB; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Konstantinopoulos PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Clin Cancer Res ; 28(15): 3356-3366, 2022 08 02.
Article em En | MEDLINE | ID: mdl-35443043
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Terapia Neoadjuvante Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Terapia Neoadjuvante Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article